Glen Santangelo
Stock Analyst at Jefferies
(2.39)
# 2,482
Out of 4,896 analysts
76
Total ratings
46.81%
Success rate
0.39%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $8.32 | -3.85% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $64.97 | +23.13% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $9.12 | +42.54% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $37.36 | +36.51% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $5.11 | +17.42% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $20.20 | +8.91% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $16.21 | +23.38% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $22.90 | -21.40% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $23.22 | +3.38% | 4 | Sep 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $47.89 | -51.97% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $16.40 | +40.24% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $32.52 | +35.30% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $14.90 | +14.09% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $154.96 | +48.43% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.81 | +1,139.77% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $21.66 | +223.18% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $8.09 | +579.85% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $9.18 | +74.29% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $4.38 | +219.63% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $60.20 | -23.59% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $94.48 | -15.33% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $3.89 | +619.79% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $26.72 | +161.98% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $8.40 | +1,328.57% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.64 | -24.24% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.75 | +890.52% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.92 | +818.37% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $64.78 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $709.59 | -76.18% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $160.97 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $73.44 | +11.66% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $202.28 | +23.59% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $11.52 | +577.08% | 1 | Dec 4, 2017 |
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $8.32
Upside: -3.85%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $64.97
Upside: +23.13%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $9.12
Upside: +42.54%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $37.36
Upside: +36.51%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $5.11
Upside: +17.42%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $20.20
Upside: +8.91%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $16.21
Upside: +23.38%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $22.90
Upside: -21.40%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $23.22
Upside: +3.38%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $47.89
Upside: -51.97%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $16.40
Upside: +40.24%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $32.52
Upside: +35.30%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $14.90
Upside: +14.09%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $154.96
Upside: +48.43%
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $0.81
Upside: +1,139.77%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $21.66
Upside: +223.18%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $8.09
Upside: +579.85%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $9.18
Upside: +74.29%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $4.38
Upside: +219.63%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $60.20
Upside: -23.59%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $94.48
Upside: -15.33%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $3.89
Upside: +619.79%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $26.72
Upside: +161.98%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $8.40
Upside: +1,328.57%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.64
Upside: -24.24%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.75
Upside: +890.52%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $3.92
Upside: +818.37%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $64.78
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $709.59
Upside: -76.18%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $160.97
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $73.44
Upside: +11.66%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $202.28
Upside: +23.59%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $11.52
Upside: +577.08%